Rinvoq
- Product NDC
- 0074-2310
- 11-digit product format
- 000742310
- Labeler code
- 0074
- Product ID
- 0074-2310_6c4bad0a-5930-4bb7-8509-6a8c6f279082
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Upadacitinib
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- NDA211675
- Marketing category
- NDA
- Marketing start
- 2019-08-16
- Substance
- UPADACITINIB
- Active strength
- 30 mg/1
- Pharmacologic classes
- Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rinvoq
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| UPADACITINIB | 30 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 4RA0KN46E0 |
| Rxcui | 2196894, 2196900, 2590051, 2590054, 2596957, 2596960, 2681015, 2681019 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed0545f8-aad9-4991-8385-8bf3a9114f4f | Product name | 2 | 20250213 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-2310-20 | Rinvoq | 14 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 14 | 100 | |
| 0074-2310-30 | Rinvoq | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0074-2310-30 | EA - Each | 0074-2310 | 044f9ebe-eea6-4ee1-9177-1cd610ebb2e2 | 1 | 2022-02-07 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2196900 | RINVOQ 15 MG 24HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590054 | RINVOQ 30 MG 24HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596960 | RINVOQ 45 MG 24HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681019 | RINVOQ LQ 1 MG in 1 mL Oral Solution | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681015 | upadacitinib 1 MG in 1 mL Oral Solution | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2196894 | upadacitinib 15 MG 24HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596957 | upadacitinib 45 MG 24 HR Extended Release Oral Tablet | PSN | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2196900 | 24 HR upadacitinib 15 MG Extended Release Oral Tablet [Rinvoq] | SBD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590054 | 24 HR upadacitinib 30 MG Extended Release Oral Tablet [Rinvoq] | SBD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596960 | 24 HR upadacitinib 45 MG Extended Release Oral Tablet [Rinvoq] | SBD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681019 | upadacitinib 1 MG/ML Oral Solution [Rinvoq] | SBD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2196894 | 24 HR upadacitinib 15 MG Extended Release Oral Tablet | SCD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590051 | 24 HR upadacitinib 30 MG Extended Release Oral Tablet | SCD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596957 | 24 HR upadacitinib 45 MG Extended Release Oral Tablet | SCD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681015 | upadacitinib 1 MG/ML Oral Solution | SCD | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2196900 | 24 HR Rinvoq 15 MG Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596960 | 24 HR Rinvoq 45 MG Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681019 | Rinvoq 1 MG per 1 ML Oral Solution | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681019 | Rinvoq 1 MG/ML Oral Solution | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2196900 | RINVOQ 15 MG 24 HR Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590054 | Rinvoq 30 MG 24 HR Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596960 | Rinvoq 45 MG 24 HR Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2681015 | upadacitinib 1 MG per 1 ML Oral Solution | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2590051 | upadacitinib 30 MG 24 HR Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
| 2596957 | upadacitinib 45 MG 24 HR Extended Release Oral Tablet | SY | 2966aec7-2ef0-923c-d8ff-fe1a957bf095 | 100 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0074-2310-20 | 00074231020 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20) | 2019-08-16 | 0000-00-00 | Yes | No | Current |
| 0074-2310-30 | 00074231030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30) | 2019-08-16 | 0000-00-00 | No | No | Current |